Key Highlights of the Report:

Growing Demand: Demand for tissue diagnostics in the MENA region is increasing owing to enhanced awareness and continual innovations in the healthcare industry.

 Technological Advancements: The utilization of the latest diagnostic equipment improves the accuracy and speed through which tissues are examined.

Challenges Addressed: Importantly, the report describes how the strategies have been put in place to counter issues of logistics and infrastructure regarding tissue diagnostics in the MENA region.

Market Opportunities: A great potential for investment and partnership in the field of tissue diagnostics can be identified in the healthcare industry of the MENA region.

Future Outlook: The tissue diagnostics market is expected to have a positive outlook in the MENA region as a result of the continued improvement in the health sector and changes in the needs of patients.

According to a new report by Univdatos, The MENA Tissue Diagnostic Market valued at USD 253.18 million in the year 2023 and is expected to grow at a strong CAGR of around 7.36% during the forecast period. This is mainly because of the rise in disease incidence and the growing need for diagnostics, which include key factors that are creating a push towards the tissue diagnostic market in the MENA region. Chronic diseases, including cancer, cardiovascular diseases, and diabetes, are on the increase in the Gulf Cooperation Council countries, including Qatar, Bahrain, Oman, Jordan, and Lebanon, because of old-age population, changes in lifestyle and influences factors, and environmental impacts. As per the United Nations Population Fund (UNFPA), in 2024, the United Arab Emirates is going through a demographic transition as the number of persons aged 60+ is expected to increase more than six-fold between 2020 - 2050 from about 311,000 (3.1% of the total population) to 2 million (19.7%).

Access sample report (including graphs, charts, and figures): https://univdatos.com/reports/mena-tissue-diagnostic-market?popup=report-enquiry

The report suggests that Tissue Diagnostic resources in the MENA region had a significant impact on the Tissue Diagnostic industry in the MENA region. Some of how this impact has been felt include:

January 2024: The acquisition of LumiraDx's point-of-care testing technology by Roche for potentially USD 350 million and Cytek Biosciences' purchase of DiaSorin's Luminex flow cytometry business for USD 46.5 million are indicative of the smaller-scale deals.

In August 2022: Al-Futtaim Health and Abbott announced a strategic partnership aimed at improving the standards of advanced laboratory diagnostics in Dubai. The aim is to provide everything from access to efficient, reliable, and cost-effective pathology testing services to advanced patient care.

February 2021, the Advanced Medical Technology Association (AdvaMed) inked a MoU, entering a formal relationship with MECOMED, MEA’s medical devices, imaging, and diagnostics trade association. The collaboration facilitated information sharing between both organizations and increased the ability to strengthen this market.

In 2021, Medovate, a medical device manufacturer in the U.K., announced a partnership in the Middle East. The Cambridge-based specialist has teamed up with Kuwait’s Omneya Medical Co. to distribute its SAFIRA (SAFer Injection for Regional Anesthesia) device in the Gulf country.

Apart from this, in recent years, Saudi Arabia has dominated the market in MENA, and North Africa has enhanced the growth of the tissue diagnostic industry:

Saudi Arabia held a dominant share of the market in 2023. Saudi Arabia's robust healthcare sector and ambitious healthcare transformation agenda propel the growth of tissue diagnostics in the MENA healthcare market. As the largest economy in the region, Saudi Arabia has made significant investments in healthcare infrastructure, technology adoption, and medical research to enhance the quality of patient care. Tissue diagnostics support Saudi Arabia's healthcare goals by facilitating early disease detection, accurate diagnosis, and personalized treatment strategies. The country's Vision 2030 agenda emphasizes the importance of preventive healthcare and the integration of digital health solutions, aligning with the role of tissue diagnostics in promoting population health and improving clinical outcomes. Moreover, Saudi Arabia's strong commitment to medical education and training ensures a skilled workforce capable of delivering high-quality tissue diagnostic services to meet the needs of its growing population.

Click here to view the Report Description & TOC : https://univdatos.com/reports/mena-tissue-diagnostic-market

Conclusion

In conclusion, tissue diagnostics remains one of the most promising advanced fields in the delivery of healthcare services in the MENA region, with the prospects for early diagnosis, individual treatment approaches, and better outcomes. Thus, the MENA countries can enhance the field of tissue diagnostics through the promotion of the use of technologies and the creation of favorable regulatory policies for the development of technologies to improve the future of healthcare in the region.

Key Offerings of the Report

Market Size, Trends, & Forecast by Revenue | 2024−2032

Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities

Market Segmentation – A detailed analysis By Product; By Technology; By Application; By End-User

Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Contact Us:

UnivDatos

Contact Number - +1 978 733 0253

Email - contact@univdatos.com 

Website - www.univdatos.com

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/